Drug General Information
Drug ID
D06DRD
Former ID
DNC006899
Drug Name
Chrysamine -G
Drug Type
Small molecular drug
Indication Discovery agent Investigative [528454]
Structure
Download
2D MOL

3D MOL

Formula
C26H18N4O6
Canonical SMILES
C1=CC(=CC=C1C2=CC=C(C=C2)NN=C3C=CC(=O)C(=C3)C(=O)[O-])N<br />N=C4C=CC(=O)C(=C4)C(=O)[O-].[Na+].[Na+]
InChI
1S/C26H18N4O6.2Na/c31-23-11-9-19(13-21(23)25(33)34)29-27-17-5-1-15(2-6-17)16-3-7-18(8-4-16)28-30-20-10-12-24(32)22(14-20)26(35)36;;/h1-14,27-28H,(H,33,34)(H,35,36);;/q;2*+1/p-2/b29-19+,30-20+;;
InChIKey
WRWZSSFDRPAHPA-BEYAFGAESA-L
PubChem Compound ID
Target and Pathway
Target(s) Amyloid beta A4 protein Target Info Inhibitor [528454]
KEGG Pathway Notch signaling pathway
Alzheimer's disease
Reactome Nuclear signaling by ERBB4
Degradation of the extracellular matrix
Regulated proteolysis of p75NTR
NRIF signals cell death from the nucleus
Activated NOTCH1 Transmits Signal to the Nucleus
Constitutive Signaling by NOTCH1 PEST Domain Mutants
Constitutive Signaling by NOTCH1 HD+PEST Domain Mutants
EPH-ephrin mediated repulsion of cells
WikiPathways Notch Signaling Pathway
Signaling by ERBB4
Signaling by NOTCH3
Signaling by NOTCH4
Signaling by NOTCH1
Signaling by NOTCH2
Notch Signaling Pathway
Alzheimers Disease
Signalling by NGF
References
Ref 528454J Med Chem. 2006 Oct 5;49(20):6111-9.Curcumin and dehydrozingerone derivatives: synthesis, radiolabeling, and evaluation for beta-amyloid plaque imaging.
Ref 528454J Med Chem. 2006 Oct 5;49(20):6111-9.Curcumin and dehydrozingerone derivatives: synthesis, radiolabeling, and evaluation for beta-amyloid plaque imaging.

If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.